article thumbnail

Scrub-a-Dub-Dub: FTC is Cleansing the Orange Book of Device Patents

FDA Law Blog: Biosimilars

Koblitz — As we have noted for the last year or so, the FTC has been on a mission to clean up the Orange Book by removing what it deems to be “improper” patents. FTC, deep in its foray into the Orange Book, filed an Amicus Brief in the case arguing that the patents do not claim any FDA-approved drug. And on X (R.I.P.

FDA 116
article thumbnail

Helping Knowledge Workers Be More Productive

Perficient: Drug Development

The term “knowledge worker” was first coined by Peter Drucker in his book, The Landmarks of Tomorrow ( 1959). Drucker defined knowledge workers as high-level workers who analyze data and apply theoretical/analytical knowledge to develop insights, trends, products, and services.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FTC Continues to Rage Against Device Patent Listings in the Orange Book

FDA Law Blog: Biosimilars

Koblitz — The FTC appears to be on a mission to cleanse the Orange Book of patents it deems improperly listed. For the second time in recent years, the FTC has filed an Amicus Brief explaining exactly which patents should not be in the Orange Book.

FDA 59
article thumbnail

Multiclass Text Classification Using LLM (MTC-LLM): A Comprehensive Guide

Perficient: Drug Development

What are the requirements for traveling with a pet? Booking Issues Emails under this intent are related to the booking process or flight details. You are an AI language model tasked with classifying whether a customer’s message to the Acme airline company is a “BOOKING INQUIRY.”

article thumbnail

To List or Not to List; That is the Question – The FTC Signals the Potential for Greater Scrutiny of Patent Information Submissions to FDA

FDA Law Blog: Biosimilars

Karst — Listing patent information in the Orange Book is a matter of judgment, but that judgment call is about to get a bit more scrutiny. Last week, the FTC held a Listening Session about the listing of patents in the Orange Book, which concluded with a unanimous vote to issue a Policy Statement.

FDA 105
article thumbnail

Free Orange Book PDF Library from DrugPatentWatch

Drug Patent Watch

The FDA Orange Book, or Approved Drug Products with Therapeutic Equivalence Evaluations, is the definitive source to link drugs with the patents that protect them. The post Free Orange Book PDF Library from DrugPatentWatch appeared first on DrugPatentWatch - Make Better Decisions. Over the years we’ve had….

FDA 40
article thumbnail

Suspend Reality – 6 Steps to Move from Fantasy to Execution

Perficient: Drug Development

billion), music ($43 billion), and book publishing ($26.8 Years ago, I found the book series by Jean-Marie Dru and it immediately hit home for me. When I was in high school, I recall an assignment where each student in the class was given a character from a book we had just read, and we each wrote an essay on our character.